Clinical Trials Browser

Phase 1/2 × Terminated × temsirolimus × Clear all

NCT02423954 2018-07-02

NivoPlus

Phase 1/2 Terminated

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Pancreatic Neoplasms, Colorectal Neoplasms

NCT00921310 2016-12-13

Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer

Phase 1/2 Terminated

12 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT00877773 2016-08-25

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Phase 1/2 Terminated

44 enrolled 5 charts

Advanced Cancers

NCT01020305 2014-10-13

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Phase 1/2 Terminated

5 enrolled 6 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT01015664 2012-12-17

Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 1/2 Terminated

Squamous Cell Carcinoma of Head and Neck